Protalix BioTherapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PBDA.F | PRTA | VRXA | RGNX | GENO.ST | TARA | |
|---|---|---|---|---|---|---|
| Market cap | 190.15M | 430.72M | 134.34M | 508.96M | 1.46B | 138.87M |
| P/E (TTM) | 11.8 | — | — | — | 72.3 | — |
| Forward P/E | 59.0 | -6.4 | — | -2.6 | 46.2 | -1.4 |
| Price/book | 3.0 | 1.5 | -0.7 | 5.8 | 4.8 | 0.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +9.31% | −20.06% | −90.96% | −30.98% | −4.08% | −45.72% |
| Today | +0.21% | +2.19% | −4.04% | +1.05% | +2.60% | −2.49% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PBDA.F news ›Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026
Nov 03, 2026, 06:50 ET Company to host conference call and webcast at 8:00 a.m. ET Management will host a conference call to discuss the financial results and provide an update on recent corporate and regulatory developments. Webcast…
Protalix BioTherapeutics (NYSE:PLX) vs. Anixa Biosciences (NASDAQ:ANIX) Head to Head Survey
Posted by Sarita Garza on Oct 25th, 2026 Anixa Biosciences (NASDAQ:ANIX – Get Free Report) and Protalix BioTherapeutics (NYSE:PLX – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- prnewswire.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.